These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1771518)
1. [Thrombocyte function as an indicator of thrombophilia in a cross-sectional study of patients with angiographically confirmed coronary sclerosis]. Misselwitz F; Reimann H; Lange H; Norden C Vasa Suppl; 1991; 32():291-4. PubMed ID: 1771518 [No Abstract] [Full Text] [Related]
2. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Cesari F; Marcucci R; Caporale R; Paniccia R; Romano E; Gensini GF; Abbate R; Gori AM Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424 [TBL] [Abstract][Full Text] [Related]
3. Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis). Valenti R; Marcucci R; Comito V; Marrani M; Cantini G; Migliorini A; Parodi G; Gensini GF; Abbate R; Antoniucci D JACC Cardiovasc Interv; 2015 Oct; 8(12):1563-70. PubMed ID: 26386764 [TBL] [Abstract][Full Text] [Related]
4. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516 [TBL] [Abstract][Full Text] [Related]
5. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058 [TBL] [Abstract][Full Text] [Related]
9. Acute coronary artery stent thrombosis following rapid renewal of functional platelets: implications for intensified antiplatelet therapy. Schulz C; Schömig A; Kastrati A Thromb Haemost; 2006 Sep; 96(3):384-6. PubMed ID: 16953284 [No Abstract] [Full Text] [Related]
10. Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients. De Luca G; Verdoia M; Cassetti E; Schaffer A; Di Giovine G; Bertoni A; Di Vito C; Sampietro S; Aimaretti G; Bellomo G; Marino P; Sinigaglia F; Blood Coagul Fibrinolysis; 2013 Sep; 24(6):619-24. PubMed ID: 23689272 [TBL] [Abstract][Full Text] [Related]
11. Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease. Ekmekçi H; Işler I; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A Thromb Res; 2006; 117(3):249-54. PubMed ID: 16378831 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet effect of aspirin in patients with coronary artery disease. Grove EL Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204 [TBL] [Abstract][Full Text] [Related]
13. High clopidogrel dose in patients with chronic kidney disease having clopidogrel resistance after percutaneous coronary intervention. Liang J; Wang Z; Shi D; Liu Y; Zhao Y; Han H; Li Y; Liu W; Zhang L; Yang L; Zhou Y Angiology; 2015 Apr; 66(4):319-25. PubMed ID: 24913197 [TBL] [Abstract][Full Text] [Related]
14. The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting. Breet NJ; de Jong C; Bos WJ; van Werkum JW; Bouman HJ; Kelder JC; Bergmeijer TO; Zijlstra F; Hackeng CM; Ten Berg JM Thromb Haemost; 2014 Dec; 112(6):1174-81. PubMed ID: 25231776 [TBL] [Abstract][Full Text] [Related]
16. Aspirin in coronary artery disease: an appraisal of functions and limitations. Würtz M Dan Med J; 2015 Apr; 62(4):B5011. PubMed ID: 25872543 [TBL] [Abstract][Full Text] [Related]